NeuroMetrix (NASDAQ:NURO) Share Price Crosses Above 200-Day Moving Average – Here’s Why

NeuroMetrix, Inc. (NASDAQ:NURO)’s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.88 and traded as high as $4.10. NeuroMetrix shares last traded at $4.02, with a volume of 44,328 shares trading hands.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on NeuroMetrix in a research note on Thursday. They issued a “sell” rating on the stock.

NeuroMetrix Stock Performance

The firm has a 50 day moving average price of $4.02 and a two-hundred day moving average price of $3.88. The company has a market cap of $8.20 million, a P/E ratio of -0.88 and a beta of 2.20.

NeuroMetrix (NASDAQ:NURO) last released its quarterly earnings data on Tuesday, November 5th. The medical device company reported ($0.75) EPS for the quarter. The business had revenue of $0.59 million for the quarter. NeuroMetrix had a negative net margin of 203.71% and a negative return on equity of 42.56%. During the same quarter in the previous year, the business posted ($1.66) earnings per share.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.